Back
Ecolab, Inc. 10K Form
Buy
55
ECL
Ecolab, Inc.
Last Price:
$264.55
Seasonality Move:
3.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | ECL/Ecolab, Inc. Quarterly |
| 2024-02-23 | 10K | ECL/Ecolab, Inc. Annual |
| 2023-11-02 | 10Q | ECL/Ecolab, Inc. Quarterly |
| 2023-08-03 | 10Q | ECL/Ecolab, Inc. Quarterly |
| 2023-05-04 | 10Q | ECL/Ecolab, Inc. Quarterly |
| 2023-02-24 | 10K | ECL/Ecolab, Inc. Annual |
Receive ECL News And Ratings
See the #1 stock for the next 7 days that we like better than ECL
ECL Financial Statistics
Sales & Book Value
| Annual Sales: | $15.7B |
|---|---|
| Cash Flow: | $529.7M |
| Price / Cash Flow: | 48.59 |
| Annual Sales: | $34.31 |
| Price / Book: | 7.71 |
Profitability
| EPS (TTM): | 6.95250 |
|---|---|
| Net Income (TTM): | $2B |
| Gross Margin: | $6.8B |
| Return on Equity: | 22.09% |
| Return on Assets: | 8.75% |
Ecolab, Inc. Earnings Forecast
Key Ecolab, Inc. Financial Ratios
-
The Gross Profit Margin over the past 45 years for ECL is 43.47%.
-
The Selling, General & Administrative Expenses for ECL have been equal to 26.86% of Gross Profit Margin.
-
The Research & Development expenses have been 1.32% of Revenue.
-
The Interest Expense is 15.87% of Operating Income.
-
The Net Earning history of ECL is 13.54% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 30 years.
Ecolab, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | ECL |
| CUSIP: | 278865 |
| Website: | ecolab.com |
Debt
| Debt-to-Equity Ratio: | 0.91 |
|---|---|
| Current Ratio: | 1.7 |
| Quick Ratio: | 1.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 35.88 |
|---|---|
| Forward P/E Ratio: | 31.17 |
ECL Technical Analysis vs Fundamental Analysis
Buy
55
Ecolab, Inc. (ECL)
is a Buy
Is Ecolab, Inc. a Buy or a Sell?
-
Ecolab, Inc. stock is rated a BuyThe current Ecolab, Inc. [ECL] share price is $264.42. The Score for ECL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.